化学复合镀Ni-P-TiO_2光催化降解次甲基蓝

以钛酸丁酯为原料通过溶胶 凝胶法制备出粒径 30nm左右的纳米TiO2 ,利用化学复合镀在钢铁基底上形成Ni P 纳米TiO2 复合镀层 ,该复合镀层对次甲基蓝有较好的光催化降解作用 ,其催化性能与粉末状纳米TiO2 的催化性能大致相当。     

离子液体用于燃料油深度脱硫的研究进展

首先介绍了加氢催化脱硫和其他脱硫技术的特点,综述了近年来国内外利用离子液体在萃取脱硫、萃取脱硫与氧化脱硫耦合、萃取脱硫与生物脱硫耦合等方面的研究。认为离子液体萃取脱硫具有操作简便、可循环使用、无需氢气、环境友好、能深度脱硫等特点,是一项具有广阔发展前景的技术。若要实现该技术的工业化应用,还需进一步加强离子液体在合成工艺、脱硫选择性及回收再生等方面的研究。     

OFDM-MIMO系统及其频率同步分析

多媒体业务对无线通信的带宽与品质提出了更高的要求，OFDM和MIMO由于满足了这一需求被越来越多的无线通信标准采用所为底层的调制和传输技术。频率同步问题是OFDM—MIMO物理层设计中正确解调的前提和基础，本文介绍了OFDM—MIMO的原理、特点和频率同步问题的研究现状。     

Novel algorithms for shared segment protection

The major challenges in designing survivable schemes are how to allocate a minimal amount of spare resources (e.g., bandwidth) using fast (e.g., polynomial-time) algorithms, and, in case a failure occurs, to be able to recover quickly from it. All existing approaches invariably make tradeoffs. We propose novel shared segment protection algorithms which make little or no compromise . We develop an elegant integer linear programming (ILP) model to determine an optimal set of segments to protect a given active path. Although the ILP approach is useful for a medium-size network, it is too time consuming for large networks. Accordingly, we also design a fast heuristic algorithm based on dynamic programming to obtain a near-optimal set of segments. Although the heuristic algorithm has a polynomial time complexity, it can achieve a bandwidth efficiency as high as some best-performing shared path protection schemes and, at the same time, much faster recovery than these shared path protection schemes. The proposed scheme is also applicable to a wide range of networking technologies, including Internet Protocol and wavelength-division multiplexing networks under the generalized multiprotocol label switched framework.     

C51嵌套汇编子程序在阻抗测试仪研制中的应用

C51嵌套汇编子程序，充分发挥了两种语言自的优势，介绍了C51调用汇编子程序的接品规则，并通过阻抗测试仪程序开发的例子予以详细说明。     

可膨胀尾管悬挂器技术及其应用

可膨胀管悬挂器(ELH)作为尾管固井、完井工艺中一项革新型工具,可以成功地解决常规悬挂器因其原理和结构特点带来的固井施工难题及重叠段固井质量差等问题,成为下一代悬挂器研究的重点。文中以实体膨胀悬挂器系统为例,介绍了其结构原理及应用情况。     

Achieving fast and bandwidth-efficient shared-path protection

Dynamic provisioning of restorable bandwidth guaranteed paths is a challenge in the design of broad-band transport networks, especially next-generation optical networks. A common approach is called (failure-independent) path protection, whereby for every mission-critical active path to be established, a link (or node) disjoint backup path (BP) is also established. To optimize network resource utilization, shared path protection should be adopted, which often allows a new BP to share the bandwidth allocated to some existing BPs. However, it usually leads the backup paths to use too many links, with zero cost in term of additional backup bandwidth, along its route. It will violate the restoration time guarantee. In this paper, we propose novel integer linear programming (ILP) formulations by introducing two parameters (/spl epsi/ and /spl mu/) in both the sharing with complete information (SCI) scheme and the distributed partial information management (DPIM) scheme. Our results show that the proposed ILP formulations can not only improve the network resource utilization effectively, but also keep the BPs as short as possible.     

Rheology in Processing of in Situ Composites of Polypropylene and Low Melting Poing Metals

The low melting point metallic tin powder or alloy of tin and lead was blended with polypropy-lene. A kind of in situ composite has been prepared. The variations of torque were studied when the composites were mixed in Haake torque rheogeniometer. By way of capillary extrusion, effects upon rheology of the in situ com-posites of the low melting point metals (LMPM) and coupling agent for their different variety and content, were investigated. From flow curves, the results indicate that in situ composites mixed with the LMPM are a kind of pseudoplastic fluid. If the LMPM were melted, the higher the content of the LMPM , the lower apparent viscosity of composites. Meanwhile, when the coupling agent is added into composites, the viscosity of composite will go up first and drop then. This shows that the LMPM have a promoter flow action on the polypropylene.     

Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support

4-Hydroperoxycyclophosphamide (4-HC), a commonly used marrow-purging agent, is active against many tumors, but is also toxic to normal marrow progenitors. Amifostine (WR-2721) is a sulfhydryl compound with chemoprotectant activity. Preclinical studies using suspensions of bone marrow and breast cancer cells demonstrated that ex vivo treatment with amifostine followed by 4-HC resulted in protection of marrow progenitors, with no compromise in the antitumor effect of 4-HC. This fact stimulated the development of a clinical trial. Bone marrow was harvested from 15 poor-prognosis breast cancer patients and randomly assigned to ex vivo treatment with amifostine followed by 4-HC (amifostine + 4-HC), or treatment with 4-HC alone. High-dose chemotherapy was then administered followed by infusion of the purged autologous bone marrow support (ABMS). Leukocyte engraftment, defined as a white blood cell count > or = 1 x 10(9)/L, was achieved in an average of 26 days for patients whose marrow was purged with amifostine + 4-HC versus 36 days for patients whose marrow was purged with 4-HC alone (P = .032). The average number of platelet transfusions (12 v 29; P = .017) and days of antibiotic therapy (28 v 40; P = .012) were significantly less for patients whose marrow was exposed to amifostine + 4-HC, compared with 4-HC alone. Unpurged backup marrow fractions were infused into three patients whose marrow was purged with 4-HC alone, because of inadequate marrow recovery. None of the patients who received amifostine + 4-HC-purged marrow required a backup marrow fraction. Complete remissions were achieved in 83% of patients with measurable disease, with no difference between the two cohorts. Forty-three percent of patients remained alive and progression-free at a mean of 13 months posttransplant. There was no significant difference in the rate or pattern of relapse for patients whose marrow was purged with amifostine + 4-HC compared with those whose marrow was purged with 4-HC alone. Ex vivo treatment of marrow with amifostine significantly shortens the time to marrow recovery, thereby reducing the risk of myelosuppressive complications in breast cancer patients receiving high-dose chemotherapy and 4-HC-purged ABMS. Since supportive care requirements are also significantly decreased, amifostine may reduce the cost of such therapy.     

Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction

The role of the external third of helix VI of the angiotensin II (AII) AT1 receptor for the interaction with its ligand and for the subsequent signal transduction was investigated by individually replacing residues 252-256 by Ala, and residues 259 or 261 by Tyr, and permanently transfecting the resulting mutants to Chinese hamster ovary (CHO) cells. Binding experiments showed no great changes in affinity of any of the mutants for AII, [Sar1]-AII, or [Sar1, Leu8]-AII, but the affinity for the nonpeptide antagonist DuP753 was significantly decreased. The inositol phosphate response to AII was remarkably decreased in mutants V254A, H256A, and F259Y. These results indicate that AT1 residues Val254, His256, and Phe259 are not involved in ligand binding but participate in signal transduction. Based in these results and in others from the literature, it is suggested that, in addition to the His256 imidazole ring, the Phe259 aromatic ring interacts with the AII's Phe8, thus contributing to the signal-triggering mechanism.